EMEA-002229-PIP01-17-M01

Key facts

Active substance
  • Dienogest
  • ethinyl estradiol (LPRI-424)
Therapeutic area
Endocrinology, -gynacology-fertility-metabolism
Decision number
P/0053/2019
PIP number
EMEA-002229-PIP01-17-M01
Pharmaceutical form(s)
Prolonged-release tablet
Condition(s) / indication(s)
Prevention of pregnancy
Route(s) of administration
Oral use
Contact for public enquiries
Exeltis France S.A.

Tel. +34 913021560
E-mail: enrico.coli@exeltis.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating